RTW Investments’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.7M Hold
4,543,895
0.81% 33
2025
Q4
$106M Hold
4,543,895
1.07% 27
2025
Q3
$90.7M Hold
4,543,895
1.12% 26
2025
Q2
$62.3M Buy
4,543,895
+709,101
+18% +$6.8M 0.89% 29
2025
Q1
$42.4M Hold
3,834,794
0.65% 31
2024
Q4
$40.8M Buy
3,834,794
+47,447
+1% +$568K 0.62% 37
2024
Q3
$48.1M Buy
3,787,347
+230,000
+6% +$3.41M 0.7% 35
2024
Q2
$59.7M Buy
3,557,347
+300,000
+9% +$4.27M 0.92% 30
2024
Q1
$48.9M Buy
3,257,347
+1,530,539
+89% +$25M 0.72% 40
2023
Q4
$25.9M Buy
1,726,808
+869,344
+101% +$11.3M 0.4% 39
2023
Q3
$12M Hold
857,464
0.25% 44
2023
Q2
$8.87M Hold
857,464
0.17% 53
2023
Q1
$7.92M Hold
857,464
0.17% 46
2022
Q4
$7.61M Hold
857,464
0.16% 52
2022
Q3
$7.13M Hold
857,464
0.16% 59
2022
Q2
$7.02M Hold
857,464
0.18% 71
2022
Q1
$7.47M Hold
857,464
0.15% 70
2021
Q4
$8.15M Hold
857,464
0.12% 85
2021
Q3
$14.4M Buy
+857,464
New +$13.6M 0.22% 70

Other funds holding URGN